Safety and Tolerability of c-MET Inhibitors in Cancer | Drug Safety
The multiple paths towards MET receptor addiction in cancer | Oncogene
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
Targeting MET in Cancer: Obstacles and Potentials
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
The role of MET in chemotherapy resistance | Oncogene
Discover MET in NSCLC | MET Aberrations
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation
Nanoscale Mapping of EGFR and c-MET Protein Environments on Lung Cancer Cell Surfaces via Therapeutic Antibody Photocatalyst Conjugates | ACS Chemical Biology
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
The METeoric rise of MET in lung cancer - Friedlaender - 2020 - Cancer - Wiley Online Library
IJMS | Free Full-Text | Role of cMET in the Development and Progression of Colorectal Cancer
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
An overview of the c-MET signaling pathway - Shawna Leslie Organ, Ming-Sound Tsao, 2011
c-MET
c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification - Annals of Oncology
